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Human individuals carrying a mutation in the mismatch repair
gene MSH2 are at increased risk of developing tumours in the
colon and endometrium (Leach et al, 1993; Kolodner et al, 1994).
Tumours which develop in these patients display microsatellite
instability (MSI) characterized by mutations at microsatellite and
other simple sequence repeat loci (Aaltonen et al, 1993; Ionov
et al, 1993 Boland et al, 1998). The majority of these tumours have
no active MSH2 protein and the elevated mutation frequency is a
consequence of non-functional mismatch repair (Leach et al, 1993;
Parsons et al, 1993). Mutations in a number of other mismatch
repair genes give rise to similar phenotypes. Germline mutations
in such mismatch repair genes are found in patients affected by
HNPCC (hereditary non-polyposis colorectal cancer – reviewed
by Modrich and Lahue, 1996; Kolodner, 1996). The underlying
cause of the increased tumour risk in HNPCC patients remains a
point of some controversy, in most cases mutation or loss of the
remaining wild type (WT) mismatch repair gene allele appears to
be required. The more difficult issue is whether somatic inactiva-
tion of the WT allele occurs at a ‘normal’ frequency or whether
mutation/loss frequencies are elevated due to Msh2 (or other
mismatch repair gene) haploinsufficiency. In the first case, the
excess risk is simply a consequence of the greater probability of
mutation of one functional allele rather than two; in the second
case a further enhancement due to cells with a single functional
allele being somewhat genetically unstable (albeit to a lesser
extent than in doubly mutant cells) is envisaged. Haplo-
insufficiency of a number of cancer-related genes has now been
reported including Atm (Barlow et al, 1999), Trp53 (Bouffler et al,
1995; Venkatachalam et al, 1998), TGFb (Tang et al, 1998) and
p27 (Fero et al, 1998).
In order to address this and related questions, a series of experi-
ments employing Msh2-deficient mice was carried out. Msh2–/–
mice develop lymphomas at high frequency and also tumours of
the small bowel at lower incidence (deWind et al, 1995, 1998;
Reitmair et al, 1995, 1996). Survival of Msh2+/– mice is compa-
rable to that of wild type animals although some evidence suggests
that tumours contribute disproportionately to the mortality of
heterozygotes (deWind et al, 1998). However, loss/mutation of the
wild type Msh2 allele and MSI, as seen in HNPCC tumours, 
is relatively rare in tumours developing in heterozygous mice
(deWind et al, 1998). The Msh2D7N mouse model employed in this
study carries a targeted deletion of Msh2 exon 7 resulting in a null
allele (Smits et al, in press). The incidence of lymphomas and
small bowel tumours observed in homozygous and heterozygous
mice closely resembles those reported for previously described
models (de Wind et al, 1995, 1998).
MATERIALS AND METHODS
Animals were bred and housed in Leiden University Medical
Center. All animal procedures were conducted according to appro-
priate local Leiden University and Dutch national ethics guidelines
and legislation. Spontaneous and X-ray induced chromosomal
aberrations were assessed in direct bone marrow metaphase pre-
parations of mutants and wild types. Age matched mice of each
genotype were irradiated with an acute dose of 3 Gy X-rays. Direct
bone marrow metaphases were made as described (Bouffler et al,
1995) from irradiated mice 1 month after exposure and age
matched control, untreated mice. All samples were scored blind,
the code being kept in Leiden while scoring was carried out at
NRPB. Preparations were examined after block staining, G-
banding or chromosome painting as described (Bouffler et al,
1996, 1997). G-banded slides were analysed using Chantal
software (Leica Microsystems Imaging Solutions Ltd). Sister-
chromatid exchange frequencies were determined in mitogen-
stimulated spleen cultures, prepared as described (Bouffler et al,
1995). Methyl nitrosourea (Sigma) was initially diluted in
dimethyl sulfoxide and further diluted in PBS immediately prior to
adding to cultures 24 hours prior to harvesting.
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The gross morphology and number of chromosomes, assessed in
block stained preparations, was normal in all three genotypes.
Some indications of elevated frequencies of minute chromosome
fragments in bone marrow cells were obtained. However, given
the difficulty in scoring such chromosomal events, further analysis
was not carried out. Painting of chromosomes 1 and 2 did not
reveal any evidence of spontaneous chromosomal instability in
any genotype (Table 1). Thus, the MSI phenotype does not appear
to lead to elevated frequencies of spontaneous translocations.
Some evidence in the literature suggests that Msh2-deficient cells
have a somewhat elevated sensitivity to ionizing radiation (Fritzell
et al, 1997; deWeese et al, 1998) and this sensitivity extends to
elevated mutability at the HPRT locus after low dose rate exposure
(deWeese et al, 1998). Thus, the in vivo induction of chromosome
aberrations by X-irradiation was examined. Sampling at one
month post-irradiation provides a reasonably accurate picture of
induced stable, persistent aberrations (Bouffler et al, 1995, 1996).
Chromosome painting indicated that the yield of exchange-type
aberrations giving rise to colour junctions (e.g. translocations and
insertions) was comparable in the three Msh2 genotypes (Table 1).
Chi-squared tests revealed no significant differences other than the
effect of radiation elevating aberration yields. As chromosome
painting analysis is not well suited to the detection of aberrations
such as deletions and inversions, metaphases were also examined
after G-banding. G-banding has the additional advantage of  exam-
ining the entire genome. These data (Table 2) also indicated that all
genotypes reacted similarly to X-irradiation, no statistically signif-
icant differences between genotypes were observed. Note that
the frequency of breakpoints per cell assessed by G-banding 
is higher than the junctions per 100 cells scored by painting as 
G-banding scores over the entire genome while painting scored
only chromosomes 1 and 2 (approximately 14% of the genome).
Bearing this proportion in mind, the frequencies of aberrations
scored by the two methods are broadly comparable.
These findings of no excessive spontaneous or induced chromo-
somal aberration formation are reflected in the observations of
others that tumours arising in a background of mismatch repair
deficiency infrequently show gross chromosomal changes
(Aaltonen et al, 1993; Lengauer et al, 1997; Eshleman et al, 1998).
The data presented here demonstrate clearly, however, that aberra-
tions of the types associated with tumorigenesis (translocations,
deletions, etc.) can be formed in the absence of mismatch repair,
i.e. intact mismatch repair systems are not required for aberration
formation. This suggests that in mismatch repair deficient cells,
mutations in genes promoting proliferation and neoplastic
development tend to take the form of sub-microscopic events
principally, perhaps, DNA base pair changes.
Sister chromatid exchanges (SCEs) are a highly sensitive indi-
cator of DNA damage induced by specific agents. Defects in
mismatch repair are associated with reduced cellular sensitivity to
and SCE induction by 06-guanine-methylating agents such as
methyl nitrosourea (MNU) (reviewed by Karran and Bignami,
1994). Assessment of SCE in splenocytes from Msh2+/D7N,
Msh2D7N/D7N and wild type littermates revealed no effect of the
mutation on baseline frequencies (Fig. 1). SCE induction was
strongly reduced in Msh2–/– splenocytes (Fig. 1), and to a lesser
extent in Msh2 heterozygotes. Thus, Msh2 shows haploinsuffi-
ciency in this assay. Western analysis does not detect a difference
in Msh2 protein level between wild type and heterozygote ES cells
(RF, unpublished observation) most probably due to limitations of
sensitivity. MNU-induced SCEs are generally attributed to persis-
tent DNA breaks caused by ‘futile repair’ opposite O6-methyl-
guanine residues by mismatch repair enzymes (see Karran and
Bignami, 1994; Kaina et al, 1997). These persistent lesions
contribute to cytotoxicity and SCE formation. In the absence of
mismatch repair (Msh2–/– cells) few persistent lesions are
produced. Hence, mismatch repair defective cells are resistant to
the cell killing effects of O6-guanine methylating agents (Karran
and Bignami, 1994; deWind et al, 1995). The remaining alkyl
lesions promote mutation (Andrew et al, 1998; Toft et al, 1999;
Reitmair et al, 1997). However, elevated mutation frequencies
have not been observed in Msh2+/– cells (Reitmair et al, 1997;
Andrew et al, 1998; Toft et al, 1999). By contrast, the reduction 
in MNU-induced SCE observed here in Msh2+/– cells (Fig. 1),
suggests that mismatch repair is compromised by Msh2 haplo-
insufficiency. The apparent discrepancy between these data and
the mutation studies may be reconciled by the observation that
Msh2 also plays a role in the signalling of apoptosis (Humbert
et al, 1999; Toft et al, 1999). Haploinsufficiency of Msh2 may exert
a negative effect on its repair function but not on its capacity to
signal apoptosis. Therefore, Msh2+/– cells with low induced SCE
frequencies (and so, by implication, elevated O6-methyl guanine
burdens) are successfully channelled into apoptosis prior to
mutations being fixed. Msh2+/– ES cells appear as sensitive to
MNNG as wild-type cells (deWind et al, 1995) indicating that
apoptosis is functional in heterozygotes. Thus, while Msh2
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Table 1 Spontaneous and X-ray induced stable chromosome aberrations
assessed by painting of chromosomes 1 and 2
Genotype X-ray dose/ Cells scored Junctions/
sample time 100 cellsa
+ + 0 Gy 159 0
3 Gy/1 month 250 18
+ – 0 Gy 102 0.98
3 Gy/1 month 297 14.5
–– 0G y 4 1 0
3 Gy/1 month 219 16.9
aFrequency of junctions between painted and unpainted chromosome
fragments per 100 cells. In this experiment the majority of junctions are due
to translocations, some insertions, dicentrics, Robertsonian translocations
and two coloured fragments were also seen.
Table 2 G-band analysis of chromosomal aberrations in wild type and Msh2
deficient mouse bone marrow cells 1 month following 3 Gy X-irradiation in
vivo
Cells Aberrationsa Breakpoints
Genotype
scored
RT TT TD ID INS Rb
per cellb
++ 18 8 0 0 4 3 0 1.8
+– 18 2 1 1 9 3 0 1.8
–– 24 4 1 2 7 1 1 1.3
aRT – reciprocal translocation, TT – terminal translocation, TD – terminal
deletion, ID – interstitial deletion, INS – insertion, Rb – Robertsonian
translocation.
bCalculated scoring 1 breakpoint for TT, TD and Rb, 2 breakpoints for RT and
ID, 3 breakpoints for INS.haploinsufficiency can be effectively measured by the MNU-
induced SCE assay, there would appear to be no reason to expect
this to contribute to mutagenesis or carcinogenesis in the mouse.
Effects of Msh2 in the heterozygous state have been observed
following low dose rate ionizing radiation exposure. deWeese 
et al. (1998) found Msh2+/– cells to have a greater resistance to low
dose rate radiation, and showed indications of elevated mutation
frequencies. As with X-ray-induced chromosomal aberrations
(Tables 1 and 2), in the present studies, no effect of Msh2 defi-
ciency was observed using SCEs as an endpoint (Fig. 1). The high
dose rate employed here may be masking effects which would
otherwise be seen with low dose rates. Furthermore, X-rays are
only a weak inducer of SCEs despite being a potent carcinogen.
The latter also underscores the lack of correlation between SCE
induction and cancer.
In summary, it is reported here that haploinsufficiency of Msh2
in mice can be revealed by MNU-induced SCE analysis. No
phenotypic effect of loss of one or two Msh2 alleles was detected
with regard to spontaneous or X-ray induced structural chromo-
some aberrations. The data presented here add to the evidence
accumulating which indicates that haploinsufficiency for some
cancer related genes, including Msh2, has detectable phenotypic
effects.
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Figure 1 Sister chromatid exchange in wild type (diamonds) and Msh2+/–
(solid circles) and Msh2–/– (open circles) splenocytes induced by MNU (A)
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